Makeup Tutorials Natural Look | Beginners Makeup Tutorial | DIY Makeup Tutorial Life Hacks for Girls Best Makeup … …
Day: October 20, 2022
Mpowered Health Launches xChange, the Nation’s First Consumer Mediated Healthcare Data Exchange
The healthcare exchange enables nearly 200 million people to share their medical records with caregivers, plans, providers and other organizations.
Mpowered Health launches xChange
xChange is the Nation’s first consumer mediated health data exchange platform
LOS ALTOS, Calif. – October 20, 2022 – (Newswire.com)
Mpowered Health, a consumer healthcare marketplace, today announced that it successfully launched its xChange, the nation’s first consumer mediated healthcare data exchange.
The exchange enables health plans, health systems and other healthcare organizations to request and obtain medical records from consumers with their consent. Consumers can now conveniently share records with family members and caregivers in addition to healthcare organizations they receive care from.
“There are over 100 million individuals in Medicare and Medicaid, who are vulnerable and in need of caregiver support. The xChange makes it easy for such consumers to share important information about their health with the people and the organizations that support them,” says Nandini Devi, Founder & CEO of Mpowered Health. “Consumers can control at a granular level who sees what information. This offering is the lynchpin of our vision to empower consumers to take control of their healthcare experience while enabling healthcare organizations to serve their consumers more effectively.”
Consumers can connect to over 600 healthcare organizations such as health systems, medicare advantage & medicaid plans across the country including national payers, blues and regional plans. The Mpowered Health App enables nearly 200 million people across the country to access their medical records, coverage & explanation of benefits information from all these plans and health systems. In addition, the platform delivers a personalized shopping experience for consumers seeking to enroll in medicare and exchange health plans. Mpowered Health is the first healthcare platform in the United States to offer consumers such a convenience at scale.
Founded in 2019, Mpowered Health is a rapidly growing healthcare marketplace that provides a convenient platform for healthcare organizations to acquire, engage and retain consumers, while giving consumers a voice, the transparency, the choice, the access and the convenience they need to manage their own and their family’s health care.
Mpowered Health was featured in the Inc. Magazine and CIO Today in 2022 and as one of the Top Healthcare Interoperability Solution Providers by Healthcare TechOutlook.
About Mpowered Health
Mpowered Health is a consumer-driven healthcare technology company committed to creating a better healthcare experience for consumers and healthcare enterprises. The California-based company empowers consumers to take charge of their healthcare by providing mobile-led solutions that improve transparency, choice, access and convenience. The company, in recognizing that consumer empowerment cannot be a zero-sum game, provides enterprise solutions in compliance, consumer acquisition & engagement to enable healthcare organizations to serve their consumers more effectively and achieve their organizational goals.
For more information, visit us at www.mpoweredhealth.com
Media Contact: [email protected]
Contact Information:
Mpowered Health
Press
[email protected]
9740335480
Press Release Service
by
Newswire.com
Original Source:
Mpowered Health Launches xChange, the Nation’s First Consumer Mediated Healthcare Data Exchange
South Beach Detox Extending Tailored Services to Executives and Business Professionals
South Beach Detox is offering an executive-level treatment experience to business professionals.
South Beach Detox South Beach Detox
…
CliniOps Announces Strategic Partnership With My Total Health
Collaboration will accelerate and streamline gastroenterology (GI) clinical trials with an end-to-end platform for patient recruitment, enrollment, and management
…
RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms
RBMA Executive Director Bob Still decries Medicare cuts that would ‘damage the health of the American people’
RPAN Logo
RPAN Logo
WASHINGTON – October 20, 2022 – (Newswire.com)
A new study of current or eligible Medicare recipients conducted on behalf of the Radiology Patient Action Network shows that nearly half of women indicate that they have not received a mammogram in the last three years. Conducting and released during Breast Cancer Awareness Month, the study also found that 80 percent of Americans are concerned with proposed cuts to Medicare, and 90 percent of Americans view maintaining Medicare coverage as important.
“As policymakers continue to propose cuts to Medicare, it is clear any new cuts would worsen health inequities and damage the health of the American people,” said Bob Still, Executive Director of the RBMA. “At a time when patients are already having difficulty receiving the care they need — like mammography screenings proven to detect and prevent breast cancer — members of Congress should take note of these findings and protect Medicare.”
Dr. Kellie Schenk, a board-certified diagnostic radiologist with EPIC Imaging, PC, in Oregon and Imaging for a Cause participant, underscored the severity of the survey’s mammography findings. “Breast cancer is the most commonly diagnosed cancer among women and, if not caught and treated early, can be disfiguring and deadly. We recommend average-risk women receive mammography screenings every year beginning at age 40 and high-risk women talk to their doctor about screenings prior to 40 to increase the chances of early detection, which not only saves lives but makes treatment much easier and less disruptive for patients and their families. It is alarming that nearly half of Medicare-aged women haven’t received their annual mammogram given the benefits of screening in this age group, and we encourage them to get one scheduled as soon as possible. It is clear that further cuts to Medicare providers and vital screening services would only exacerbate this issue by limiting appointments and compromising quality of care.”
In addition to survey respondents’ concern for Medicare cuts and lack of mammography screenings, 1 in 4 current patients reported having difficulty scheduling doctors’ appointments due to delays or rescheduling. Almost half of all respondents said they would be less likely to support a member of Congress if they advocate for cuts.
The survey was conducted Sept. 25 through Sept. 27, 2022. The national survey sample consists of 1,632 Americans either enrolled in Medicare or Medicare-eligible. Margin of Error is +/-2.5% with a 95% level of confidence. The study was jointly sponsored by the Medical Imaging and Technology Alliance (MITA), Imaging for a Cause, and the Radiology Business Management Association (RBMA) and conducted by the Remington Research Group.
About Imaging for a Cause
Imaging for a Cause Foundation (ICF) is a 501(c)(3) nonprofit foundation that coordinates communication between imaging centers and Federally Qualified Community Health Centers. It has a decade-long history of fostering charitable care for thousands of patients, from Virginia to Minnesota to Washington State.
About MITA
The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging technology. For more information, visit www.medicalimaging.org.
About RBMA
The Radiology Business Management Association (RBMA) is an industry-leading organization comprised of more than 2,100 professionals who focus on the business of radiology. RBMA members support diagnostic imaging, interventional radiology and radiation oncology providers in the full spectrum of practice settings. RBMA connects members nationwide to valuable information, education, and practice-related resources and serves as an authoritative industry voice on behalf of shared member interests.
Contact Information:
Will Sweet
RBMA
[email protected]
Press Release Service
by
Newswire.com
Original Source:
RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms
One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial Experience
Talkiatry’s implementation of Cedar Pay brings a consumer-focused payment experience to a national patient base
NEW YORK – October 20, 2022 – (Newswire.com)
Talkiatry, a leading provider of high-quality, in-network psychiatric care and one of the largest employers of psychiatrists in the United States, announced today that it has partnered with Cedar, an enterprise healthcare engagement platform that improves the end-to-end consumer financial journey, to enhance the online billing experience for its rapidly expanding patient base.
Launched in 2020, Talkiatry is increasing the accessibility and affordability of high-quality psychiatric care. In network with over 60 major insurance plans, Talkiatry also conducts virtual visits that make it easy for patients to be seen. Talkiatry’s practice employs hundreds of psychiatrists from diverse backgrounds across a range of specialties—from child and adolescent to adult to geriatric—and uses proprietary technology to personalize care and improve outcomes in previously unachievable ways.
“In psychiatry, billing has long been a challenge for patients,” said Robert Krayn, Talkiatry’s co-founder and CEO. “It’s opaque and complex, and 45% of psychiatrists don’t even accept insurance. We’re changing that. We want our patients to focus on their health, not on trying to decipher confusing statements, and Cedar is an important part of how we use technology to improve the patient experience.”
Cedar Pay, Cedar’s post-visit patient engagement and payment platform, delivers a more streamlined patient financial journey and eases the consumer burden of paying for healthcare. Through Cedar Pay, Talkiatry will be able to empower their national patient base to better manage their healthcare bills through consumer-friendly statements, optimized outreach and flexible payment options.
“It is often difficult for Americans to access mental health treatment, due to factors like cost of care and lack of in-network providers,” said Florian Otto, Cedar’s co-founder and CEO. “At Cedar, our mission is simple: empower people to easily and affordably pursue the care they need, and we are looking forward to partnering with our first psychiatry provider, Talkiatry, as they enhance their digital strategy to meet patients where they are. And, with a simplified payments experience, their psychiatry providers will be able to focus on providing the best quality care.”
Cedar Pay is now live and available for Talkiatry’s patients.
About Talkiatry
Talkiatry is a national mental health practice that provides in-network psychiatry and therapy. They were co-founded by a patient and a triple-board-certified psychiatrist to solve the problems both groups face in accessing and providing the highest quality mental healthcare. 60% of adults in the U.S. with a diagnosable mental illness go untreated every year because care is inaccessible, while 45% of clinicians are out of network with insurers because reimbursement rates are low and paperwork is unduly burdensome. With innovative technology and a human-centered philosophy, Talkiatry provides patients with the care they need—and allows psychiatrists to focus on why they got into medicine. Learn more at www.talkiatry.com and follow us on Instagram, Facebook, and LinkedIn.
About Cedar
Cedar is committed to improving the healthcare billing experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with a personalized journey—all powered by data science and interactive design. For Cedar clients, this leads to increased payments, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end payments experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedIn, Twitter, Facebook and YouTube.
Contact Information:
Jenny Fiegoli
Cedar
[email protected]
Hirsch Leatherwood
Talkiatry
[email protected]
Press Release Service
by
Newswire.com
Original Source:
One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial Experience
Inspire Medical Systems, Inc. Expands Therapy Access to Thousands of Federal Medical Facilities Through SDVOSB Partner, Lovell Government Services, Inc.
Inspire and Lovell are proudly partnered Inspire is now available on major government contract vehicles through Lovell, SDVOSB
PENSACOLA, Fla. – …
Scitech and the Plough Center Announce Manufacturing Agreement
The Contract Manufacturing Agreement Will Provide the Clinical Supply of ST-001, SciTech’s Lead Drug Candidate for Cancer
GROSSE POINTE FARMS, Mich. – October 20, 2022 – (Newswire.com)
SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug Delivery Systems. The Plough Center will deliver the clinical supply of SciTech’s lead cancer drug candidate, ST-001 nanoFenretinide. Delivery of the drug is expected in Q4 2022, which will be immediately followed by SciTech’s first human clinical trial using ST-001 for Lymphoma. (ClinicalTrials.gov Identifier: NCT04234048).
Earle Holsapple, President of SciTech Development, said, “SciTech chose The Plough Center for their expertise in drug delivery manufacturing in addition to their intimate knowledge of combining and processing nanoparticles. We are confident that SciTech has selected the best possible partner and that this relationship will continue as we move forward, not only with ST-001, along with other drugs in our pipeline. This is a major milestone for SciTech as we rapidly approach our human clinical trials.”
“We are excited to serve as the contract manufacturer for ST-001. We are extremely eager to work with SciTech in its mission to cure several cancer types,” said Dr. Harry Kochat, Director of Operations and Business Development of The Plough Center. “ST-001 nanoFenretinide combines the SciTech Delivery Platform (SDP) and the promising drug fenretinide as a broadly applicable cancer therapeutic. The Plough Center will utilize our comprehensive NanoSpace formulation platform to provide ST-001 for clinical trials. Our in-house NanoSpace platform can produce nanosuspensions, nanoemulsions, and liposomal encapsulation products.” The Plough Center specializes in developing and manufacturing complex, early-stage investigational drugs.
About SciTech Development
SciTech Development LLC is a clinical-stage pharmaceutical company that has developed a patented, nanoparticle drug delivery platform (SDP) that maximizes the bioavailability of water-insoluble therapeutics. SciTech’s lead drug candidate ST-001 nanoFenretinide combines SDP and the drug fenretinide as a broadly applicable anticancer drug. ST-001 has an FDA Investigational New Drug (IND) approval, is Orphan Drug designated, and is Phase 1 clinical trial ready. More information about SciTech can be found at www.SciTechSDP.com.
About The Plough Center
The mission of The Plough Center for Sterile Drug Delivery Solutions is to help patients by expediting efforts to bring innovative, life-saving medicines to market. The Plough Center is a US-FDA registered cGMP sterile drug manufacturing facility owned by the University of Tennessee Health Science Center in Memphis. Plough assists universities, scientific communities, and the pharmaceutical industry in the manufacture and delivery of therapeutic advances that will improve patient standard of care. More information about The Plough Center can be found at https://www.uthsc.edu/plough-center/.
Contact Information:
Harry Kochat, PhD.
Director of Operations & Business Development
[email protected]
David Schaffer
Director Investor Relations
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Scitech and the Plough Center Announce Manufacturing Agreement
Reproductive Technology Startup Inti Labs Sets Sights on Global Infertility Trend
The company offers innovative and accessible diagnostic solutions that improve IVF success rates
Inti Labs logo Logo
PALO ALTO…
Toetal Solutions Secures $1,800,000 in New Financing to Pursue Product Development and Regulatory Approval
MALVERN, Pa. – October 20, 2022 – (Newswire.com)
Toetal Solutions, Inc., a foot and ankle medical device company, announced it had closed $1,800,000 in additional financing from Runway Healthcare, LP, with participation from Runway Healthcare investors. Toetal Solutions plans to use the proceeds to finalize product development and obtain regulatory clearance for its flagship product, the Ziptoe™ Hammertoe System.
The Ziptoe Hammertoe System enables foot and ankle surgeons to address rigid hammertoe deformities with a simple, easy-to-use implant. “The system has been thoughtfully designed with surgeon input to address the common pitfalls of the devices available to surgeons today. The Ziptoe implant is easy to use and provides an incredibly stable fusion from the moment it is deployed. Additionally, it enables surgeons to address the MTPJ if necessary, addressing the Toetal Pathology with a Toetal Solution,” stated Nick Romansky, DPM. The Ziptoe system includes a proprietary deployable nitinol implant that comes sterile packed with all necessary disposable instrumentation to perform the procedure in any surgical setting efficiently and effectively.
“This financing should enable our team to finalize the development of the Ziptoe Hammertoe System and achieve FDA approval, fundamentally changing how surgeons address forefoot deformities. We aim to improve patient outcomes while making the surgeons’ lives easier,” said Co-Founder and Chief Technology Officer William Rhoda.
Toetal Solutions is Runway Healthcare’s second portfolio company. The medical device accelerator combines capital and direct management to bring commercially ready opportunities to the medical device industry following regulatory approval. Runway Healthcare will seek to transition Toetal Solutions’ ownership to a larger multi-national healthcare company for commercialization.
About Toetal Solutions, Inc.:
Toetal Solutions was founded in 2021 to create easy-to-use and clinically effective solutions for foot and ankle deformities. The Ziptoe™ Hammertoe System features a sterile packed procedure kit and implant to address ridged hammertoe deformity.
About Runway Healthcare, LP:
Runway Healthcare is an early-stage MedTech Accelerator focused on early-stage technology in the Orthopedic, Cardiovascular, and Neurology sectors. Runway finances and manages the product development process of its portfolio companies. Upon navigating a portfolio company through the regulatory process, Runway Healthcare will seek to transition its portfolio companies’ ownership to larger multi-national healthcare companies for commercialization.
Forward-Looking Statements:
This press release contains “forward-looking statements” concerning the development of Toetal Solutions products, the potential benefits and attributes of those products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Toetal Solutions undertakes no obligation to update any forward-looking statements for any reason.
Inquiries: [email protected]
Contact Information:
Jeff O’Donnell, Jr
President and CEO
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Toetal Solutions Secures $1,800,000 in New Financing to Pursue Product Development and Regulatory Approval